Home » Topics » BioWorld Science, Respiratory

BioWorld Science, Respiratory
RSS

Results reported from the first-in-human trial of CHF-6366 in healthy male volunteers

May 19, 2021

New phase II trial evaluates CBP-201 for moderate to severe persistent asthma

May 13, 2021

Phase I trial of Ampion in long COVID receives IRB approval

May 11, 2021

Diffusion reports final data from phase Ib study of TSC in hospitalized COVID-19 patients

May 11, 2021

New TRPA1 antagonists identified at Boehringer Ingelheim

May 10, 2021

Keymed evaluates CM-310 in phase II for chronic rhinosinusitis with nasal polyposis

May 10, 2021

Boehringer Ingelheim discovers TRPA1 antagonists

May 6, 2021

SAN-903 reduces lung inflammation and fibrosis in mouse model of IPF

May 4, 2021

Mesoblast reports 60-day results on remestemcel-L in COVID-19 related ARDS

April 30, 2021

New IRAK-4 inhibitors identified at Bayer

April 28, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...